Arca Biopharma | Des Atouts





Des Atouts Changement Date
Alterity Therapeutics Limited AUD 27.32M 6.07M 2023-06
Amgen USD 90.59B 445M 2025-12
Arca Biopharma USD 509.25M 151.83M 2025-09
Biogen USD 29.44B 232M 2025-12
Brainstorm Cell Therapeutics USD 1.38M 1.19M 2025-09
Bristol-Myers Squibb USD 96.89B 2.21B 2025-09
Capricor Therapeutics USD 126.44M 7.13M 2025-09
Cipla INR 401.64B 27.77B 2025-09
Clal Biotechnology ILS 158.39M 24.3M 2023-12
Compugen USD 97.84M 8.68M 2025-09
CSL USD 39.4B 957M 2025-06
Cytokinetics USD 1.44B 210.92M 2025-09
Daiichi Sankyo JPY 3.82T 252.52B 2025-12
Gilead Sciences USD 58.53B 2.81B 2025-09
GlaxoSmithKline GBP 61.12B 221M 2025-12
Grifols EUR 23.29B 3.35M 2025-09
Laboratory Of America USD 18.26B 201.7M 2025-09
Myriad Genetics USD 728.1M 50.8M 2025-09
Otsuka Holdings JPY 3.96T 170.24B 2025-09
Pfizer USD 208.73B 2.64B 2025-09
United Therapeutics USD 7.35B 556.9M 2025-09


Arca Biopharma Des Atouts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.